Advertisement

Topics

Sanofi Pasteur MSD AG Company Profile

09:24 EST 13th December 2018 | BioPortfolio

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops vaccines, originating from research by both shareholders, and ensures they are available to people across Europe, providing protection from disease for all age groups.

Location

Lättichstrasse 6
BAAR
6340
Switzerland

Contact

Phone: 41 41 761 56 65
Fax: 41 41 761 43 34
Email: webmastercorp@spmsd.com


News Articles [650 Associated News Articles listed on BioPortfolio]

Sanofi Pasteur: Creating Vaccines, Protecting Lives

Sanofi Pasteur produce more than 1 billion doses of vaccines yearly to immunize more than 500 million people in the world. During BIO 2015, Roman Chicz, Head of External R&D at Sanofi Pasteur, told Fi...

Sanofi Pasteur and Translate Bio to develop new mRNA vaccines

Global vaccine company Sanofi Pasteur has signed a research and development (R&D) collaboration and exclusive licensing agreement with therapeutics company...Read More... The post Sanofi Pasteur a...

Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership

Sanofi’s global vaccines unit Sanofi Pasteur will partner with Translate Bio to develop mRNA vaccines for up to five undisclosed infectious disease pathogens, through a collaboration that the mRNA t...

Sanofi Pasteur to buy license of Translate's mRNA technology in $805m deal

Sanofi Pasteur, the vaccines business of French pharma firm Sanofi, has agreed to acquire exclusive license of Translate Bio’s mRNA technology to develop messenger RNA (mRNA) vaccines in a deal that...

Sanofi Pasteur partners with Translate Bio for infectious disease vaccines

Sanofi Pasteur has teamed up with Translate Bio to develop and sell mRNA vaccines for up to five infectious disease targets.

Yellow fever: A new method for testing vaccine safety

(Institut Pasteur) Scientists from the Institut Pasteur, the CNRS and Sanofi Pasteur have recently developed a novel alternative method to animal testing that can be used to verify the safety of vacci...

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines

It hasn’t been proven yet that synthetic messenger RNA molecules (mRNA) can be effective medicines. But their promise as a source for new vaccines, primarily for cancer, has enticed multiple pharmac...

Sanofi Pasteur ends Clostridium difficile vaccine programme

Drugs and Medications [50 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Allegra d 12 hour allergy and congestion [Rebel Distributors Corp]

Allegra-D 12 Hour Allergy and Congestion

Allegra d 12 hour allergy and congestion [Chattem, Inc.]

Allegra-D 12 Hour Allergy and Congestion

Hiprex(methenamine hippurate tablets usp) [sanofi-aventis U.S. LLC]

HIPREX(methenamine hippurate tablets USP)

Taxotere [sanofi-aventis U.S. LLC]

These highlights do not include all the information needed to use TAXOTERE safely and effectively. See full prescribing information for TAXOTERE. TAXOTERE (docetaxel) Injection Concentrate, Intraveno...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning.

CYD-TDV is the first licensed dengue vaccine for individuals 9-45 (or 60) years of age. Using 12% of the subjects enroled in phase-2b and phase-3 trials for which baseline serostatus was measured, the...

Multiple clones of metallo-β-lactamase-producing Acinetobacter ursingii in a children hospital from Argentina.

Acinetobacter spp. are opportunistic pathogens being A. baumannii the most frequently identified in nosocomial settings. A. ursingii was mainly described as causing bacteremia and outbreaks in neonata...

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.

The live-attenuated Japanese encephalitis chimeric virus vaccine JE-CV (IMOJEV®, Sanofi Pasteur) elicits a robust antibody response in children, which wanes over time. Clinical efficacy is based on a...

Low-Grade Inflammation Decreases Emotion Recognition - Evidence from the Vaccination Model of Inflammation.

The ability to adequately interpret the mental state of another person is key to complex human social interaction. Recent evidence suggests that this ability, considered a hallmark of 'theory of mind'...

Dupixent, a New Entrant In the Asthma Lists.

Sanofi and Regeneron's Dupixent (dupilumab)-which is already approved for atopic dermatitis-has an FDA action date of October 20 for its asthma indication. It will join Nucala, (mepolizumab), Cinqair ...

Clinical Trials [87 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America

Primary objectives: - To describe the immune response to each dengue serotype before and after each vaccination with sanofi pasteur's CYD dengue vaccine. - To evaluate t...

Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand

The present clinical study will assess the immunogenicity and reactogenicity of Sanofi Pasteur's DTacP-IPV// PRP~T combined vaccine (Pentavac™ or Pentaxim™) as a three-dose primary vac...

Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry

The Sanofi Pasteur Quadrivalent Influenza Vaccine (QIV) Pregnancy Registry will be a prospectively recruited pregnancy surveillance program designed to collect and analyze information on v...

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

This trial will evaluate the use of a tetravalent vaccine against dengue. Primary objectives: - To describe the immune response to dengue before and after each vaccination with ...

Study of Sanofi Pasteur's DTaP-IPV Hep B-PRP-T Combined Vaccine in Infants Who Previously Received Hepatitis B Vaccine

Phase III, open, mono-center study in 177 infants who received a dose of Hep B vaccine at birth or within 1 month after birth. Infants will receive Sanofi Pasteur's DTaP-IPV-Hep B-PRP-T c...

Companies [81 Associated Companies listed on BioPortfolio]

Sanofi Pasteur MSD AG

Sanofi Pasteur MSD is the only European company dedicated exclusively to vaccines and was founded in 1994, as a joint venture between Sanofi Pasteur and Merck and Co. Inc.Sanofi Pasteur MSD develops v...

sanofi-pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

Sanofi Pasteur

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...

sanofi pasteur S.A.

It is rare for a company's history to be so tightly interwoven with the history of a major health care discovery. Sanofi pasteur is the result of the meeting of three exceptional destinies, those of m...

March of Dimes and Sanofi Pasteur Inc.

More Information about "Sanofi Pasteur MSD AG" on BioPortfolio

We have published hundreds of Sanofi Pasteur MSD AG news stories on BioPortfolio along with dozens of Sanofi Pasteur MSD AG Clinical Trials and PubMed Articles about Sanofi Pasteur MSD AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sanofi Pasteur MSD AG Companies in our database. You can also find out about relevant Sanofi Pasteur MSD AG Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record